報價延遲最少15分鐘:2025/07/15 04:47 EDT
盤前時段
|
||||
|
-- 
|
|
|
常規時段
|
|
|
|
|
||||||||||||
|
|
|
|
|
15.18
|
|
|
| 價值評估 |
|
盈利(現時/預測)
1.41/--
|
|
企業價值
221.81M
|
| 資產負債 |
|
每股賬面淨值
23.85
|
| 現金流量 |
|
現金流量率
0.14
|
| 損益表 |
|
收益
44.99M
|
|
每股收益
3.07
|
|
同行比較
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
報價延遲最少15分鐘：2025/07/15 04:47 EDT
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| SWK Holdings Corp is a healthcare capital provider. The company offers financing solutions to various life science companies, institutions, and inventors. It involves monetizing cash flow streams derived from commercial-stage products and related intellectual property through royalty purchases and financings, as well as through the creation of synthetic revenue interests in commercialized products. Through its wholly-owned subsidiary, it also provides non-discretionary investment advisory services to institutional clients. The company's operating segments are Finance Receivables and Pharmaceutical Development Services. It generates maximum revenue from the Finance Receivables segment. |
